baber/WOPTO huggingface dataset:
Patent AU-2012238290-A1 (AU)
Title: Methods And Apparatus For Reducing Protein Content In Sperm Cell Extenders
Inventor: SCHENK JOHN L
IPC: A01N1/02
Filed: 2012-10-10
Abstract: The invention relates to methods and apparatus for reducing protein content in sperm cell extenders. More specifically, this invention may involve eliminating the protein content of a cryoprotectant component used in a multiple step sperm cell extension process. The invention may be particularly suited for use in sorted sperm applications. The invention may include one or more of the following features: techniques for reducing protein content in a sperm cell extender, techniques for reducing protein content in a cryoprotectant-containing B fraction of a sperm cell extender; techniques for preparing sperm cell extenders that do not require clarification; techniques for preparing low density gradient sperm cell extenders suitable for centrifugation; techniques for reducing protein content between individual steps in preparing a sperm cell extender, and techniques for establishing novel values of reduced protein content in sperm cell extenders.
Patent AU-2012240669-A1 (AU)
Title: Spectroscopic analyser
Inventor: KROUSE DONAL PAUL
IPC: G01J3/427
Filed: 2012-04-10
Abstract: An analyser (10) for identifying or verifying or otherwise characterising a liquid based drug sample (16) comprising: an electromagnetic radiation source (11) for emitting electromagnetic radiation (14a) in at least one beam at a sample (16), the electromagnetic radiation comprising at least two different wavelengths, a sample detector (17) that detects affected electromagnetic radiation resulting from the emitted electromagnetic radiation affected by the sample, and a processor (18) for identifying or verifying the sample from the detected affected electromagnetic radiation, wherein each wavelength or at least two of the wavelengths is between substantially 1300nm and 2000nm, and each wavelength or at least two of the wavelengths is in the vicinity of the wavelength(s) of (or within a region spanning) a spectral characteristic in the liquid spectrum between substantially 1300nm and 2000nm.
Patent AU-2012245067-A1 (AU)
Title: Independent and automatic incident alert device, system and method
Inventor: BOYT ADAM ANDREW
IPC: G08B21/00
Filed: 2012-04-18
Abstract: An independent and automatic alert device, system and method provides an alert transmission to a remote location in the event of an incident occurring to an object (such as a person or vehicle). Detection means detects at least one characteristic of an incident, such as speed, angle, vector, roll, yaw, heave, pitch, acceleration, deceleration, rate of deceleration (jerk), position, immersion, presence of one or more chemicals, radioactive materials or radiation, temperature, force or overall area of any impact to the object. Determination means identifies whether a detected incident requires an alert to be transmitted. Transmission means transmits an alert to the remote location based on the at least one characteristic of the incident.
Patent AU-2012263373-A1 (AU)
Title: Polyphenylene sulfide fibers and nonwoven fabric
Inventor: NAKANO YOHEI
IPC: D04H3/009
Filed: 2012-06-01
Abstract: Provided are: polyphenylene sulfide fibers which are mainly composed of a PPS resin and has excellent heat resistance and thermal bondability at the same time; and a nonwoven fabric which is configured of the fibers. The polyphenylene sulfide fibers are characterized by being mainly composed of a polyphenylene sulfide and having a sum of the crystallinity and the rigid amorphia of 30-90% (inclusive). The crystallinity is preferably 5% or more but less than 25%. A nonwoven fabric is configured using the polyphenylene sulfide fibers. The nonwoven fabric is preferably integrated by thermal bonding or mechanical interlacing.
Patent AU-2012268913-A1 (AU)
Title: Display apparatus
Inventor: LEE MIN HEE
IPC: G09F11/00
Filed: 2012-12-20
Abstract: A display apparatus including a support configured to support a display unit, and a cover formed of a flexible sheet and configured to cover the support, thereby improving the external appearance of the rear side of the display apparatus through the cover.
Patent AU-2012269260-A1 (AU)
Title: System and method for monitoring a condition of at least one nozzle
Inventor: BLENDINGER STEFAN
IPC: B03D1/14
Filed: 2012-05-29
Abstract: The invention relates to a system (1, 1', 1'') and a method for monitoring a condition of at least one nozzle (2) for spraying a two- or three-phase mixture (3, 3'). Associated with the nozzle (2) are at least one structure-borne sound sensor (4) for detecting a sound power level signal (Lw) in the region of the nozzle (2) and also at least one gas and/or liquid meter (5) for detecting a volumetric flow (Q) of gas (6) and/or liquid directed through the nozzle (2).
Patent AU-2012272689-A1 (AU)
Title: Method and product delivery mechanism with a pump
Inventor: WING HARRY EDWARD
IPC: A23L1/00
Filed: 2012-06-22
Abstract: A product delivery mechanism for a beverage dispensing system that dispenses flavor/ingredients and ice into a serving cup for mixing and/or blending. The product delivery system includes a gas operated pump for moving the flavor/ingredients from a product source to a dispensing nozzle above the serving cup. A gas restrictor is connected to an exhaust port of the pump to regulate gas flow rate and product flow rate so as to prevent splashing at the cup while operating the pump well within its rated pressure limits.
Patent AU-2012272856-A1 (AU)
Title: Microorganisms for producing 1,4-butanediol and methods related thereto
Inventor: BURGARD ANTHONY P
IPC: C12P7/04
Filed: 2012-06-21
Abstract: The invention provides non-naturally occurring microbial organisms comprising a 1,4-butanediol (BDO), 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine pathway comprising at least one exogenous nucleic acid encoding a BDO, 4-hydroxybutyryl-CoA, 4- hydroxybutanal or putrescine pathway enzyme expressed in a sufficient amount to produce BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine and further optimized for expression of BDO. The invention additionally provides methods of using such microbial organisms to produce BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine.
Patent AU-2012280277-A1 (AU)
Title: Darunavir formulations
Inventor: DELAET URBAIN ALFONS C
IPC: A61K9/20
Filed: 2012-07-06
Abstract: This invention relates to solid oral dosage forms of the HIV inhibitor darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulations thereof.
Patent AU-2012292115-A1 (AU)
Title: Genetic marker for the diagnosis of dementia with lewy bodies
Inventor: BEYER KATRIN
IPC: C12Q1/68
Filed: 2012-07-30
Abstract: Specific polymorphisms in BChE gene have been found which allow determining whether a patient suffers from dementia with Lewy bodies (DLB), and allow distinguishing it from Alzheimer's disease. The invention provides an in vitro method for the diagnosis of DLB comprising determining in a biological sample from a subject, the genotype of the following polymorphisms in butyrylcholinesterase (BChE) gene: the polymorphic site at position 3687 in NCBI Accession Number NG_009031 (i.e. SEQ ID NO: 1 ) the polymorphic site at position 4206 in SEQ ID NO: 1, the polymorphic site at position 4443 in SEQ ID NO: 1. and the polymorphic site at position 68974 in NCBI Accession Number NG_009031 (i.e. position 934 in SEQ ID NO: 26).
Patent AU-2012294460-A1 (AU)
Title: Small molecule compounds that control plant- and insect-pathogenic nematodes
Inventor: CHOE ANDREA
IPC: A01P21/00
Filed: 2012-08-08
Abstract: The present invention relates to methods of modifying nematode behavior using certain isolated modulator compounds. Also disclosed are methods of promoting or inhibiting reproduction in a nematode population, methods of promoting or inhibiting nematode aggregation at a first location, and methods of treating or preventing parasite infection of a plant.
Patent AU-2012294669-A1 (AU)
Title: Mounting fixture including an articulation joint
Inventor: CUTSFORTH ROBERT S
IPC: B23Q1/50
Filed: 2012-08-03
Abstract: A mounting fixture (10) for positioning a workpiece (4) in a desired re¬ relationship with an apparatus (6) including an articulation joint (20) for coupling first (12) and second (14) tubular members in a desired angular relationship. The articulation joint includes a first end portion clamped to an interior surface of the first tubular member and a second end portion clamped to an interior surface of the second tubular member. First and second clamping members (40a, 40b) of the articulation joint are clamped together to prevent pivotable movement between a first articulation member (22a) and a second articulation member (22b) of the articulation joint.
Patent AU-2012312050-A1 (AU)
Title: Device and method for enabling an orthopedic tool for parameter measurement
Inventor: STEIN MARC
IPC: H01M50/247
Filed: 2012-09-21
Abstract: A system for enabling a medical device. The system includes a cradle having a magnet for generating a magnetic field. The cradle supports and aligns the medical device in a predetermined orientation. Medical device placed in the cradle exposes a magnetic sensitive switch to the magnetic field of the magnet that produces a change in state of the magnetic sensitive switch. Medical device further includes a switch, indicator, logic circuitry, delay circuit, and detect circuit for coupling a power source to electronic circuitry. In a first mode of operation the medical device can be turned on and then turned off. In a second mode of operation the medical device cannot be turned off after being turned on.
Patent AU-2012319579-A1 (AU)
Title: Sense-improving agent
Inventor: KATOH KEN
IPC: A23K10/28
Filed: 2012-10-02
Abstract: The goal of the present invention is to provide a sense-improving agent that is safe and has the effect of improving dulling of peripheral senses by routine consumption or application to the skin. Another goal of the present invention is to provide a food and beverage product, feed, and cosmetic product for improving senses that have the effect of improving peripheral senses by oral ingestion or application to the skin. A sense-improving agent is provided that uses a milk-derived protein and/or milk-derived protein decomposition product as the active ingredient. The milk-derived protein and/or milk-derived protein decomposition product is capable of improving dulling of the senses, particularly the peripheral senses, and can be used in a food and beverage product, feed, or cosmetic for improving the senses.
Patent AU-2012326168-A1 (AU)
Title: Etanercept formulations stabilized with amino acids
Inventor: MANNING MARK
IPC: C07K14/81
Filed: 2012-10-18
Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions stabilized with an amino acid and suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
Patent AU-2012347292-A1 (AU)
Title: An aerosol generating device with adjustable airflow
Inventor: DUBIEF FLAVIEN
IPC: A24F40/485
Filed: 2012-12-05
Abstract: There is provided an aerosol generating system (101) for heating an aerosol-forming substrate. The aerosol generating system comprises an aerosol generating device (105) and a cartridge (103). The aerosol generating system comprises a vaporizer for heating the aerosol- forming substrate to form an aerosol, at least one air inlet (123) and at least one air outlet (125). The air inlet (123) and the air outlet (125) are arranged so as to define an air flow route between the air inlet and the air outlet. The aerosol generating system further comprises flow control means for adjusting the size of the at least one air inlet (123), so as to control the air flow speed in the air flow route.
Patent AU-2012362901-A1 (AU)
Title: System, method, and computer program for an integrated human-machine interface (HMI) of an engine-generator
Inventor: SUKUMARAN SUSEEL
IPC: B60L50/10
Filed: 2012-12-12
Abstract: In one embodiment, an engine management system (EMS) can use a human machine interface (HMI) to modify operating parameters of a set of engine generators controlled by an engine control unit (ECU). The HMI can permits authorized users to adjust a plurality of operating parameters of the engine generators in accordance with an authorization level of the authorized users. The ECU can be a standalone system operable independent of the EMS. A communication network (e.g., ARCnet) can link the EMS to the ECU, wherein the changes of the operating parameters input via the HMI are maintained over a power-cycle of the EMS. Further, changes of the operating parameters input via the HMI can be maintained even when communications over the communication network linking the engine.
Patent AU-2012363867-A1 (AU)
Title: Composite fabrication vent assembly and method of connecting
Inventor: HIKEN ALAN D
IPC: B29C33/10
Filed: 2012-06-15
Abstract: A The composite fabrication vent assembly (12) comprises a body member (14) having a first clamping surface (16), a clamping member (18) having a second clamping surface (20), and a carriage member (22) interconnecting the body member and the clamping member such that the first and second clamping surfaces are in opposing relationship. The carriage member is adapted for translating the body member and clamping member relative to one another from an open state to a closed state. When the open end of an inflatable bladder (26) is inserted between the opposed first and second clamping surfaces of the vent assembly, the clamping surfaces form an airtight seal with the open end of the bladder as the clamping surfaces are translated to the closed state. The vent assembly can then control the flow of gas into and out of the inflatable bladder through one or more passageways in the vent assembly.
Patent AU-2012379655-A1 (AU)
Title: Method for inducing UDP-glucuronosyltransferase activity using pterostilbene
Inventor: BARTOS JEREMY
IPC: A61P17/12
Filed: 2012-11-14
Abstract: A method is provided for treating an individual for a cellular proliferative disorder, including administering to the individual in need of such treatment a therapeutically effective amount of the compound pterostilbene wherein UDP-glucuronosyltransferase (UGT) activity is increased. In an embodiment, 12-HETE levels can be reduced by administration of pterostilbene.
Patent AU-2012384909-A1 (AU)
Title: System and method to improve accuracy of galvanic tool measurements
Inventor: LI SHANJUN
IPC: G01V3/22
Filed: 2012-07-12
Abstract: A system and method for improving the accuracy of galvanic tool measurements is described. The system (300) may include a survey electrode (A
Patent AU-2012390298-A1 (AU)
Title: Swellable packer having reinforcement plate
Inventor: ANDERSEN KRISTIAN
IPC: E21B23/01
Filed: 2012-09-21
Abstract: A packer assembly for use with a subterranean well can include a base pipe, at least one ring-shaped reinforcement plate which encircles the base pipe, and at least one swellable seal material which longitudinally straddles the reinforcement plate on the base pipe. A method of constructing a packer assembly can include securing at least one ring-shaped reinforcement plate to a base pipe, the plate encircling the base pipe, and then positioning at least one swellable seal material on the base pipe, the swellable seal material straddling the reinforcement plate. Another method of constructing a packer assembly can include securing at least one ring-shaped reinforcement plate to at least one swellable seal material, and then positioning the plate and the swellable seal material on a base pipe.
Patent AU-2012393559-A1 (AU)
Title: Methods and apparatus for making retreaded tires
Inventor: PAN CHINGLIN
IPC: B29D30/54
Filed: 2012-10-31
Abstract: Embodiments of the invention include methods for supporting a recessed void during retreading operations. Such methods include the steps of providing a tread having a top side and a bottom side, the tread including a recessed void recessed below the top side of the tread. Such methods also include the step of arranging the tread around an outer circumference of the tire carcass in a desired position to form an assembled retreaded tire. Such methods further include the step of arranging a removable circumferential band around the assembled retreaded tire positioned over top the recessed void and the top side of the tread. Such methods further include the steps of placing a curing membrane around at least a portion of the tire and the circumferential band and curing the retreaded tire with the circumferential band contained within the curing membrane.
Patent AU-2012393997-A1 (AU)
Title: Odor control material prepared by extrusion comprising particles encapsulated in a polymeric matrix
Inventor: FORSGREN BRUSK ULLA
IPC: A61F13/15
Filed: 2012-11-12
Abstract: The present invention relates to an odour control material consisting of a water-insoluble particulate odour control agent and a thermoplastic water-soluble carrier matrix encapsulating the odour control agent. The carrier matrix dissolves when in contact with an aqueous solution, such as urine and the odour control material is obtained by means of thermoforming. The invention relates also to a method for the preparation of the odour control material and the use of the odour control material in absorbent products. The present odour control material minimizes dusting problems caused by particulate odour control agents in production processes.
Patent AU-2012395406-A1 (AU)
Title: Vehicle body lower portion structure with side collision sensor
Inventor: KIN TETSUMASA
IPC: B62D25/20
Filed: 2012-11-30
Abstract: Provided is a vehicle body lower portion structure provided with a side collision sensor which can detect a collision earlier because of the improvement of the structure of the body. A first load transmission member (40) having a substantially Z-shaped vertical cross-section is disposed within the closed cross-section (30) of a rocker (12). A first joint section (40B) of the first load transmission member (40) is joined while being sandwiched between the upper flange (26D) of a rocker outer panel (26) and the upper flange (28D) of the rocker inner panel (28), and a second joint section (40C) is joined to the intermediate section, in the height direction, of the vertical wall section (26A) of the rocker outer panel (26). The body section (40A) obliquely connects the first joint section (40B) and the second joint section (40C) and is adapted to transmit a load toward the upper wall section (28B) of the rocker inner panel (28) through the shortest distance, the load being inputted into the rocker outer panel (26) during a side collision.
Patent WO-2013188924-A1 (WO)
Title: Conductive portions in insulating materials
Inventor: MAJUMDER MAINAK
IPC: B82Y40/00
Filed: 2013-06-21
Abstract: A method of forming a conductive portion (30) in an insulating material (10). The insulating material includes carbon (11) and at least one other constituent (12). The method includes exposing the insulating material to ions (20) to preferentially remove the other constituent.
Patent WO-2014032115-A1 (WO)
Title: A reusable inwardly collapsible void former
Inventor: COMERFORD ERNEST FREDERICK
IPC: B28B7/30
Filed: 2013-08-30
Abstract: A re-useable void former for forming voids in concrete structures adapted to be positioned in wet concrete being of a flexible and elastic material to allow the void former to pucker inwardly when unsupported; a retainer adapted to support and maintain the outer shape as the concrete sets; a remover adapted to engage the void former on withdrawing the retainer wherein the unsupported void former is able to pucker and be pulled from the void thus formed for reuse. A method of use of the invention.
Patent AU-2013201604-A1 (AU)
Title: Anti-angiogenic agents and methods of use
Inventor: QU ZHICAN
IPC: A01N43/54
Filed: 2013-03-18
Abstract: 5184G-AU-D3 Use of terfenadine in the manufacture of a medicament for inhibiting the growth or metastasis of a human breast or human ovarian tumor. Also, use of terfenadine in the manufacture of a medicament for treating a disease or disorder associated with angiogenesis in a human in need thereof, wherein the disease or disorder is selected from the group consisting of restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, endometriosis, macular degeneration, neovascular glaucoma, and adiposity. A method of inhibiting the growth or metastasis of breast or ovarian cancer in a person or treating a disease or disorder associated with angiogenesis in a human is also provided. WO 2009/023299 PCT/US2008/060186 0 ca CD cc IDC o 00 a)) Lc CU > L ) U) CC! 0>UO 1 ISDd -CD1 4(1) Cu) IOAUO 1 IUOJ 0 0USITT BE RL 6
Patent AU-2013202755-A1 (AU)
Title: Activatable binding polypeptides and methods of identification and use thereof
Inventor: DAUGHERTY PATRICK SEAN
IPC: A61K39/395
Filed: 2013-04-06
Abstract: The present disclosure provides activatable binding polypeptides (ABPs), which contain a target binding moiety (TBM), a masking moiety (MM), and a cleavable moiety (CM). The present disclosure provides activatable antibody compositions, which contain a TBM containing an antigen binding domain (ABD), a MM and a CM. Furthermore the present disclosure also provides ABPs which contain a first TBM, a second TBM and a CM. The ABPs exhibit an "activatable" conformation such that at least one of the TBMs is less accessible to target when uncleaved than after cleavage of the CM in the presence of a cleaving agent capable of cleaving the CM. The disclosure further provides libraries of candidate ABPs, methods of screening to identify such ABPs, and methods of use. The disclosure further provides ABPs having TBMs that bind VEGF, CTLA-4, or VCAM, ABPs having a first TBM that binds VEGF and a second TBM that binds FGF, as well as compositions and methods of use.
Patent AU-2013211059-A1 (AU)
Title: Targeted mutant alpha-helical bundle cytokines
Inventor: TAVERNIER JAN
IPC: C07K16/32
Filed: 2013-01-17
Abstract: The present invention relates to a modified α-helical bundle cytokine, with reduced activity via a α-helical bundle cytokine receptor, wherein said α-helical bundle cytokine is specifically delivered to target cells. Preferably, said α-helical bundle cytokine is a mutant, more preferably it is a mutant interferon, with low affinity to the interferon receptor, wherein said mutant interferon is specifically delivered to target cells. The targeting is realized by fusion of the modified α-helical bundle cytokine to a targeting moiety, preferably an antibody. The invention relates further to the use of such targeted modified α-helical bundle cytokine to treat diseases. A preferred embodiment is the use of a targeted mutant interferon, to treat diseases, preferably viral diseases and tumors.
Patent AU-2013217048-A1 (AU)
Title: Mobile human challenge-response test
Inventor: KALGI AVINASH
IPC: H04L9/32
Filed: 2013-02-07
Abstract: Methods and systems for verifying whether a user requesting an online account is likely a human or an automated program are described. A request for an online account may be received from a mobile device. A human challenge-response test adapted for displaying on a mobile device is displayed on the mobile device. Upon viewing the human challenge-response test, the user enters the user's solution to the human challenge-response test on the mobile device. A response hash value is created based on the user's solution. The response hash value is sent to an account request server for verification.